Details for New Drug Application (NDA): 062609
✉ Email this page to a colleague
The generic ingredient in MYTREX A is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for 062609
Tradename: | MYTREX A |
Applicant: | Savage Labs |
Ingredient: | neomycin sulfate; triamcinolone acetonide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | EQ 3.5MG BASE/GM;0.1% | ||||
Approval Date: | May 23, 1986 | TE: | RLD: | No |
Complete Access Available with Subscription